| Literature DB >> 34886290 |
Jayden R Hunter1, Rebecca M Meiring2,3, Ashley Cripps4, Haresh T Suppiah5, Don Vicendese6,7, Michael I Kingsley1,2, Brett A Gordon1.
Abstract
Public health movement and social restrictions imposed by the Australian and New Zealand governments in response to the COVID-19 pandemic influenced the working environment and may have affected health behaviours, work ability, and job performance. The aim of this study was to determine the associations between health behaviours and work ability and performance during COVID-19 restrictions and if health behaviours were related to demographic or population factors. A cross-sectional survey was used to gather responses from 433 adult employees in Australia and New Zealand between June and August 2020. The survey requested demographic information and used the International Physical Activity Questionnaire, Work Ability Index, and the World Health Organisation's Health and Work Performance Questionnaire. Multivariate regression models were used to explore relationships between the identified variables while controlling for several possible confounders. Being sufficiently physically active was associated with higher reported physical (aOR = 2.1; p = 0.001) and mental work abilities (aOR = 1.8; p = 0.007) and self-reported job performance (i.e., lower presenteeism) (median +7.42%; p = 0.03). Part-time employees were 56% less likely (p = 0.002) to report a good or very good mental work ability. Those with existing medical conditions were 14% less likely (p = 0.008) to be sufficiently active and 80% less likely (p = 0.002) to report rather good or very good physical work ability. Being sufficiently active was associated with higher physical and mental work abilities and better job performance during the COVID-19 pandemic. Employers should support opportunities for regular physical activity and provide specific support to individuals with medical conditions or in part-time employment.Entities:
Keywords: coronavirus; employee; exercise; health promotion; physical activity; productivity; work ability
Mesh:
Year: 2021 PMID: 34886290 PMCID: PMC8657020 DOI: 10.3390/ijerph182312563
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Descriptive characteristics of the participant sample.
| Variable |
| (%) |
|---|---|---|
| Total participant sample | 433 | 100 |
| Gender | ||
| Male | 101 | 23.3 |
| Female | 325 | 75.1 |
| Non-binary | 3 | 0.7 |
| Other | 4 | 0.9 |
| Age (years) | ||
| 18–29 | 107 | 24.7 |
| 30–39 | 131 | 30.3 |
| 40–49 | 95 | 21.9 |
| 50–59 | 75 | 17.3 |
| 60+ | 25 | 5.8 |
| Residence | ||
| New Zealand | 17 | 3.7 |
| Australia | 416 | 96.3 |
| Victoria | 214 | 51.4 |
| Western Australia | 160 | 38.5 |
| New South Wales | 33 | 7.9 |
| Queensland | 3 | 0.7 |
| South Australia | 3 | 0.7 |
| Tasmania | 3 | 0.7 |
| Ethnicity | ||
| Oceanian | 222 | 51.3 |
| European | 166 | 38.3 |
| Asian | 25 | 5.8 |
| Other | 20 | 4.6 |
| Marital Status | ||
| Married | 198 | 46.8 |
| Never married | 103 | 24.3 |
| De facto | 90 | 21.3 |
| Widowed/Divorced/Separated | 32 | 7.6 |
| Level of Education | ||
| Postgraduate degree/Diploma | 185 | 42.8 |
| University/College degree | 140 | 32.4 |
| Certificate I-IV/Diploma/Advanced Diploma | 66 | 15.2 |
| Completed secondary school | 33 | 7.6 |
| Did not complete secondary school/other | 8 | 1.9 |
| Number of Dependents | ||
| 0 | 273 | 63.5 |
| 1 or 2 | 126 | 29.3 |
| 3+ | 31 | 7.2 |
| Homeschooled children during COVID-19 | ||
| Yes | 118 | 27.5 |
| No | 311 | 72.5 |
BMI, Body Mass Index (underweight, <18.5 kg·m−2; normal range, 18.5–24.99 kg·m−2; overweight, 25.00–29.99 kg·m−2; obese, ≥30.00 kg·m−2); CI, Confidence Interval; IQR, Interquartile range.
Employment characteristics of the participant sample.
| Variable |
| (%) |
|---|---|---|
| Employment Fraction | ||
| Full-time | 302 | 69.7 |
| Part-time | 131 | 30.3 |
| Employment Group | ||
| Professionals | 251 | 58.0 |
| Clerical and Administration Workers | 61 | 14.1 |
| Managers | 57 | 13.2 |
| Community and Personal Services Workers | 23 | 5.3 |
| Sales Workers | 16 | 3.7 |
| Technicians and Trades Workers | 13 | 3.0 |
| Other | 12 | 2.8 |
Health status and health-related behaviours of the participant sample.
| Variable |
| (%) |
|---|---|---|
| BMI Classification | ||
| Underweight | 4 | 1.0 |
| Normal weight | 223 | 54.0 |
| Overweight | 131 | 31.7 |
| Obese | 55 | 13.3 |
| Medical Conditions | ||
| 0 | 276 | 63.9 |
| 1 or 2 | 136 | 31.4 |
| 3+ | 20 | 4.6 |
| Prescribed Medications | ||
| Yes | 139 | 32.2 |
| No | 293 | 67.8 |
| Smoking Status | ||
| Not a smoker | 417 | 96.3 |
| Current smoker | 16 | 3.7 |
| Alcohol Consumption | ||
| 4–7 times per week | 47 | 10.9 |
| 2–3 times per week | 110 | 25.5 |
| Once per week | 92 | 21.3 |
| 2–3 times per month | 54 | 12.5 |
| Once per month | 29 | 6.7 |
| A few times per year | 52 | 12.0 |
| None in the last year | 17 | 3.9 |
| Never | 31 | 7.2 |
| Sleep Quantity: Median (IQR) | 7.0 (6.5–8.0) | |
| Sedentary Behaviour: Median (IQR) | 7.9 (6.0–10.1) | |
Current smoker (current smoker or quit in the last six months); Medical conditions (number of diagnosed medical conditions); Prescribed medications (currently taking any prescribed medications); Sedentary behaviour (hours per weekday spent sitting); Sleep quantity (average hours per night).
Aerobic and strength exercise participation.
| Strength Exercise Participation: | |||
|---|---|---|---|
| Moderate-vigorous aerobic exercise participation, | <2 days·wk−1 | ≥2 days·wk−1 | Total |
| <500 MET-min·wk−1 | 124 (30.8) | 35 (8.7) | 159 (39.5) |
| ≥500 MET-min·wk−1 | 94 (23.3) | 150 (37.2) | 244 (60.5) |
| Total | 218 (54.1) | 185 (45.9) | 403 (100.0) |
MET, Metabolic equivalent of energy expenditure.
Multivariate regression results.
| Estimated Difference | 95% CI | ||
|---|---|---|---|
| Meeting vs. not meeting the MVPA guideline | |||
| Physical Work Ability | 2.10 | 1.34–3.29 | 0.001 |
| Mental Work Ability | 1.80 | 1.18–2.83 | 0.007 |
| Relative Absenteeism | −0.33% | −5.00–4.00% | 0.880 |
| Absolute Presenteeism | 7.42% | 0.66–14.19% | 0.032 |
| Meeting vs. not meeting the strength exercise guideline | |||
| Physical Work Ability | 1.46 | 0.94–2.27 | 0.092 |
| Mental Work Ability | 1.43 | 0.94–2.18 | 0.088 |
| Relative Absenteeism | 1.25% | −3.00–6.00% | 0.572 |
| Absolute Presenteeism | 2.80% | −3.50–9.10% | 0.382 |
CI, Confidence Interval; n = 349. Adjusted odds ratio reported for physical work ability and mental work ability. Median reported for absenteeism and presenteeism.
STROBE Checklist.
| Item No. | Recommendation | Page No. | |
|---|---|---|---|
| Title and abstract | 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | 1 |
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found | 1 | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 2 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 2 |
| Methods | |||
| Study design | 4 | Present key elements of study design early in the paper | 2–3 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 2–3 |
| Participants | 6 | Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants | 3 |
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 3–4 |
| Data sources/ measurement | 8 * | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | 3–4 |
| Bias | 9 | Describe any efforts to address potential sources of bias | 2–4 |
| Study size | 10 | Explain how the study size was arrived at | 3 |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 4–5 |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | 4–5 |
| (b) Describe any methods used to examine subgroups and interactions | 4–5 | ||
| ( | 5 | ||
| Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy | 4–5 | ||
| ( | 4–5 | ||
| Results | |||
| Participants | 13 * | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 5 |
| (b) Give reasons for non-participation at each stage | 5 | ||
| (c) Consider use of a flow diagram | N/A | ||
| Descriptive data | 14 * | (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | 5–7 |
| (b) Indicate number of participants with missing data for each variable of interest | 5–8 | ||
| Outcome data | 15 * | Cross-sectional study—Report numbers of outcome events or summary measures | 5–8 |
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | 8 |
| (b) Report category boundaries when continuous variables were categorized | N/A | ||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | N/A | ||
| Other analyses | 17 | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses | 7–8 |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives | 9 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 10 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 10–11 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 10 |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 11 |
Reprinted from von Elm et al. (2007) [24]. * Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at, Annals of Internal Medicine at http://www.annals.org/ (accessed on 21 August 2021), and Epidemiology at http://www.epidem.com/ (accessed on 21 August 2021)). Information on the STROBE Initiative is available at www.strobe-statement.org (accessed on 21 August 2021).